Ameriprise’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
+26,263
| New | +$101K | ﹤0.01% | 3853 |
|
|
2024
Q4 | – | Sell |
-12,580
| Closed | -$67.8K | – | 4048 |
|
|
2024
Q3 | $67.8K | Buy |
+12,580
| New | +$67.8K | ﹤0.01% | 3854 |
|
|
2024
Q2 | – | Sell |
-126,176
| Closed | -$413K | – | 3859 |
|
|
2024
Q1 | $413K | Sell |
126,176
-39,752
| -24% | -$130K | ﹤0.01% | 3481 |
|
|
2023
Q4 | $582K | Sell |
165,928
-32,083
| -16% | -$113K | ﹤0.01% | 3397 |
|
|
2023
Q3 | $1.32M | Sell |
198,011
-5,428
| -3% | -$36.3K | ﹤0.01% | 3019 |
|
|
2023
Q2 | $1.71M | Buy |
203,439
+60,007
| +42% | +$503K | ﹤0.01% | 2951 |
|
|
2023
Q1 | $1.42M | Buy |
143,432
+3,200
| +2% | +$31.8K | ﹤0.01% | 3000 |
|
|
2022
Q4 | $976K | Buy |
140,232
+102,032
| +267% | +$710K | ﹤0.01% | 3135 |
|
|
2022
Q3 | $204K | Buy |
38,200
+14,000
| +58% | +$74.8K | ﹤0.01% | 3694 |
|
|
2022
Q2 | $97K | Sell |
24,200
-6,600
| -21% | -$26.5K | ﹤0.01% | 3785 |
|
|
2022
Q1 | $137K | Hold |
30,800
| – | – | ﹤0.01% | 3810 |
|
|
2021
Q4 | $123K | Sell |
30,800
-15,100
| -33% | -$60.3K | ﹤0.01% | 3847 |
|
|
2021
Q3 | $403K | Sell |
45,900
-100
| -0.2% | -$878 | ﹤0.01% | 3471 |
|
|
2021
Q2 | $510K | Buy |
46,000
+22,100
| +92% | +$245K | ﹤0.01% | 3451 |
|
|
2021
Q1 | $284K | Sell |
23,900
-133,658
| -85% | -$1.59M | ﹤0.01% | 3610 |
|
|
2020
Q4 | $1.08M | Sell |
157,558
-79,116
| -33% | -$543K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $1.75M | Buy |
236,674
+218,221
| +1,183% | +$1.62M | ﹤0.01% | 2731 |
|
|
2020
Q2 | $76K | Buy |
+18,453
| New | +$76K | ﹤0.01% | 3599 |
|
|
2019
Q1 | – | Sell |
-105,967
| Closed | -$879K | – | 3669 |
|
|
2018
Q4 | $879K | Buy |
105,967
+23,085
| +28% | +$191K | ﹤0.01% | 2983 |
|
|
2018
Q3 | $1.14M | Buy |
+82,882
| New | +$1.14M | ﹤0.01% | 3022 |
|